Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucero A Ramon-Luing

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Pathogens (Basel, Switzerland)|June 28, 2023
Virulence Factors of <i>Mycobacterium tuberculosis</i> as Modulators of Cell Death MechanismsLucero A Ramon-Luing, Yadira Palacios, Andy Ruiz, et al.
Plos One|November 27, 2013
Pre-exposure of Mycobacterium tuberculosis-infected macrophages to crystalline silica impairs control of bacterial growth by deregulating the balance between apoptosis and necrosisLeslie Chávez-Galán, Lucero A Ramon-Luing, Luis Torre-Bouscoulet, et al.
Journal of Infection in Developing Countries|April 11, 2021
Malnutrition and tuberculosis: the gap between basic research and clinical trialsNorma A Tellez-Navarrete, Lucero A Ramon-Luing, Marcela Muñoz-Torrico, et al.
International Journal of Molecular Sciences|January 11, 2022
<i>Mycobacterium tuberculosis</i> H37Rv Strain Increases the Frequency of CD3<sup>+</sup>TCR<sup>+</sup> Macrophages and Affects Their Phenotype, but Not Their Migration AbilityLucero A Ramon-Luing, Claudia Carranza, Norma A Téllez-Navarrete, et al.
Clinical and Experimental Immunology|October 31, 2023
Valganciclovir modulates the tumor necrosis factor axis molecules expression and CD4+ T-cell subsets in disseminated Kaposi Sarcoma patientsLucero A Ramon-Luing, Julio Flores-Gonzalez, Luis Angel García-Rojas, et al.
Cancers|January 21, 2022
Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma PatientsJulio Flores-Gonzalez, Lucero A Ramon-Luing, Ranferi Ocaña-Guzman, et al.
Molecular Medicine (Cambridge, Mass.)|July 15, 2021
Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long timeNorma A Téllez-Navarrete, Lucero A Ramon-Luing, Marcela Muñoz-Torrico, et al.
Journal of Inflammation Research|October 31, 2025
OPG and TNFR1 as Potential Biomarkers of Inflammation in Older Adults with Acute COVID-19 and Indicators of Frailty in Post-COVID-19: A Pilot StudyLucero A Ramon-Luing, Julio Flores-Gonzalez, Daniela Josefina Cataneo-Piña, et al.
Frontiers in Immunology|February 28, 2022
Fibroblasts From Idiopathic Pulmonary Fibrosis Induce Apoptosis and Reduce the Migration Capacity of T LymphocytesLeslie Chavez-Galan, Carina Becerril, Andy Ruiz, et al.
Life (Basel, Switzerland)|July 2, 2021
High Levels of TNF-α and TIM-3 as a Biomarker of Immune Reconstitution Inflammatory Syndrome in People with HIV InfectionLucero A Ramon-Luing, Ranferi Ocaña-Guzman, Norma A Téllez-Navarrete, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Pathogens (Basel, Switzerland)|June 28, 2023
Virulence Factors of <i>Mycobacterium tuberculosis</i> as Modulators of Cell Death MechanismsLucero A Ramon-Luing, Yadira Palacios, Andy Ruiz, et al.
Plos One|November 27, 2013
Pre-exposure of Mycobacterium tuberculosis-infected macrophages to crystalline silica impairs control of bacterial growth by deregulating the balance between apoptosis and necrosisLeslie Chávez-Galán, Lucero A Ramon-Luing, Luis Torre-Bouscoulet, et al.
Journal of Infection in Developing Countries|April 11, 2021
Malnutrition and tuberculosis: the gap between basic research and clinical trialsNorma A Tellez-Navarrete, Lucero A Ramon-Luing, Marcela Muñoz-Torrico, et al.
International Journal of Molecular Sciences|January 11, 2022
<i>Mycobacterium tuberculosis</i> H37Rv Strain Increases the Frequency of CD3<sup>+</sup>TCR<sup>+</sup> Macrophages and Affects Their Phenotype, but Not Their Migration AbilityLucero A Ramon-Luing, Claudia Carranza, Norma A Téllez-Navarrete, et al.
Clinical and Experimental Immunology|October 31, 2023
Valganciclovir modulates the tumor necrosis factor axis molecules expression and CD4+ T-cell subsets in disseminated Kaposi Sarcoma patientsLucero A Ramon-Luing, Julio Flores-Gonzalez, Luis Angel García-Rojas, et al.
Cancers|January 21, 2022
Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma PatientsJulio Flores-Gonzalez, Lucero A Ramon-Luing, Ranferi Ocaña-Guzman, et al.
Molecular Medicine (Cambridge, Mass.)|July 15, 2021
Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long timeNorma A Téllez-Navarrete, Lucero A Ramon-Luing, Marcela Muñoz-Torrico, et al.
Journal of Inflammation Research|October 31, 2025
OPG and TNFR1 as Potential Biomarkers of Inflammation in Older Adults with Acute COVID-19 and Indicators of Frailty in Post-COVID-19: A Pilot StudyLucero A Ramon-Luing, Julio Flores-Gonzalez, Daniela Josefina Cataneo-Piña, et al.
Frontiers in Immunology|February 28, 2022
Fibroblasts From Idiopathic Pulmonary Fibrosis Induce Apoptosis and Reduce the Migration Capacity of T LymphocytesLeslie Chavez-Galan, Carina Becerril, Andy Ruiz, et al.
Life (Basel, Switzerland)|July 2, 2021
High Levels of TNF-α and TIM-3 as a Biomarker of Immune Reconstitution Inflammatory Syndrome in People with HIV InfectionLucero A Ramon-Luing, Ranferi Ocaña-Guzman, Norma A Téllez-Navarrete, et al.
Pageof 2